or Try an Advanced Search...

    Human Cancers Stocks List

    Symbol Grade Name % Change
    GDTC C CytoMed Therapeutics Limited 2.70
    CYCCP F Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock 0.00
    SLXN F Silexion Therapeutics Ltd. -4.18
    CYCC F Cyclacel Pharmaceuticals, Inc. 2.51
    View As Page of Charts
    Related Industries: Biotechnology Shell Companies
    Related Stock Lists: Cancer Autoimmune And Inflammatory Disease Biology Biopharmaceutical Cancer Cell Cdk Inhibitor Cell Biology Cell Cycle Cell Cycle Checkpoint Cyclacel Cyclin Dependent Kinase Cyclin Dependent Kinase 2 Dna Synthesis Inflammatory Diseases PLK1 Sapacitabine Seliciclib Treatment Of Cancer Biotechnology Cancer Treatment

    Human Cancers Stocks Recent News

    Date Stock Title
    Nov 20 SLXN Silexion Therapeutics to Present at the Noble Capital Markets 20th Annual Emerging Growth Equity Conference
    Nov 20 GDTC Update on Clinical Milestone - CytoMed Therapeutics Announces First Patient Dosed in its First-in-Human Phase I Clinical Trial of Allogeneic CAR-Gamma Delta T Cell Therapy in Patients with Advanced Solid Tumours or Haematological Malignancies
    Related Industries: Biotechnology Shell Companies
    Related Stock Lists: Cancer Autoimmune And Inflammatory Disease Biology Biopharmaceutical Cancer Cell Cdk Inhibitor Cell Biology Cell Cycle Cell Cycle Checkpoint Cyclacel Cyclin Dependent Kinase Cyclin Dependent Kinase 2 Dna Synthesis Inflammatory Diseases PLK1 Sapacitabine Seliciclib Treatment Of Cancer Biotechnology Cancer Treatment
    Human Cancers

    Human cancers are diseases in which abnormal cells divide without control and can invade nearby tissues. Cancers can spread to other parts of the body through the blood and lymph systems. There are more than 100 different types of cancer, and each is classified by the type of cell that is initially affected.

    Browse All Tags